Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Join | Sign in
Home>Events

  Events

May 2015
Scientific News
Starting Antiretroviral Treatment Early Improves Outcomes for HIV-infected Individuals
NIH-funded trial results likely will impact global treatment guidelines.
Viral Immunotherapy For Skin Cancer Shows Patient Benefit
A genetically engineered herpes virus can halt the progression of skin cancer by killing cancer cells and sparking the immune system into action against tumours, a landmark clinical trial has shown.
Baylor, TGen Collaborate on Personalized Cancer Treatment Options
The companies will collaborate on precision medicine for cancer patients by offering liquid biopsies, performing gene sequencing, conducting clinical trials, and creating personalized vaccines.
Freshly Squeezed Vaccines
Microfluidic cell-squeezing device opens new possibilities for cell-based vaccines.
New Target for Treating Rheumatoid Arthritis
Many affected individuals still suffer with progressive joint damage, despite treatment. This study has discovered a new treatment target which could open a door to preventing this ongoing damage.
Shining A New Light On The Immune System
Scientists at the University of St Andrews have developed a revolutionary method of identifying cells of the immune system with “molecular fingerprints” which could pave the way for the rapid detection of conditions such as leukaemia and lymphoma from a small blood sample.
Promising Malaria and Dengue Vaccines Will Not Defeat Diseases
Although vaccination is a key part of the control of disease GlobalData stress the importance of a multi-dimensional approach.
'Redesigned' Antibodies May Neutralize HIV
With the help of a new computer program researchers have made structural alterations to an antibody, increasing its ability to tackle the AIDS virus.
How Early Childhood Vaccination Reduces Leukemia Risk
Chronic infections push ‘pre-leukemia’ cells, common in newborns, into malignancy.
Novel Class Of Antimicrobials Kills Multidrug Resistant-Tuberculosis
Researchers hope that they can end the global TB crisis by utilizing a novel bactericidal mechasnism.
Webinar: Human Recombinant Antibodies as Positive Controls and Calibrators
06 May 2015 - 06 May 2015
Webinar
Webinar: Human Recombinant Antibodies as Positive Controls and Calibrators
More information
2nd Microbiome Forum: Europe
07 May 2015 - 08 May 2015
London, UK
2nd Microbiome Forum: Europe
More information
EMBL Conference on the Human Microbiome
10 May 2015 - 12 May 2015
Heidelberg, Germany
EMBL Conference on the Human Microbiome
More information
EMBL CONFERENCE: BioMalPar XI: Biology and Pathology of the Malaria Parasite
11 May 2015 - 13 May 2015
Heidelberg, Germany
EMBL CONFERENCE: BioMalPar XI: Biology and Pathology of the Malaria Parasite
More information
20 May 2015 - 21 May 2015
Amsterdam, The Netherlands
VAX 1-2-1 2015
More information
Life Science Leadership Series: Anti-microbial Resistance
20 May 2015 - 20 May 2015
Cambridge, UK
Life Science Leadership Series: Anti-microbial Resistance
More information
27 May 2015 - 29 May 2015
Cape Town, South Africa
Africa Laborum
More information
Americas Antibody Congress 2015
27 May 2015 - 28 May 2015
San Diego, CA, USA
Americas Antibody Congress 2015
More information
World Biosimilars Congress USA 2015
27 May 2015 - 28 May 2015
San Diego, CA, USA
World Biosimilars Congress USA 2015
More information
<< 1 >>
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters